Published in Vaccine Weekly, May 3rd, 2006
New data indicate that an important part of the strong disease specific immune response induced by NeuroVax is the stimulation of FOXP3+ Regulatory T-cells. This approach could play an important role in the treatment of MS and other autoimmune diseases, such as rheumatoid arthritis, psoriasis and Crohn disease
The scientific advisory board guiding the development of NeuroVax will consist of six...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly